Literature DB >> 4056570

Effects of genetic obesity on renal structure and function in the Zucker rat.

B L Kasiske, M P Cleary, M P O'Donnell, W F Keane.   

Abstract

Although hyperphagia and obesity in the Zucker rat strain have been reported to be associated with spontaneous focal glomerulosclerosis (FGS), little is known about the age of onset and the natural history of hypertension, albuminuria, renal function, and glomerular injury in this model. We systematically investigated renal structure and function in obese male Zucker rats. Lean male littermates were used as controls. Obese rats developed glomerular mesangial matrix expansion and albuminuria by 14 weeks of age. These changes occurred despite normal inulin clearance (2.2 +/- 0.6 ml/min obese vs. 2.0 +/- 0.4 ml/min lean, P greater than 0.1) and filtration fraction (0.32 +/- 0.08 obese vs. 0.34 +/- 0.06 lean, P greater than 0.1), suggesting that increased glomerular filtration and renal plasma flow were not a prerequisite for the development of FGS. By 28 weeks of age, FGS was evident in seven of eight obese rats, and at 68 weeks of age all obese rats had marked FGS. Mean systolic blood pressure was elevated by 11 to 25 mm Hg in obese rats at all ages. Although the pathogenesis of glomerular injury is unknown, our data demonstrate that microalbuminuria, mild hypertension, and mesangial matrix expansion precede the development of progressive FGS in obese Zucker rats.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4056570

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  29 in total

Review 1.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

2.  Glomerular Lesions in Proteinuric Miniature Schnauzer Dogs.

Authors:  E Furrow; G E Lees; C A Brown; R E Cianciolo
Journal:  Vet Pathol       Date:  2016-12-22       Impact factor: 2.221

3.  Glomerulosclerosis in the diet-induced obesity model correlates with sensitivity to nitric oxide inhibition but not glomerular hyperfiltration or hypertrophy.

Authors:  Aaron J Polichnowski; Hector Licea-Vargas; Maria Picken; Jianrui Long; Rashmi Bisla; Geoffrey A Williamson; Anil K Bidani; Karen A Griffin
Journal:  Am J Physiol Renal Physiol       Date:  2015-06-24

4.  Renal function and insulin sensitivity during simvastatin treatment in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria.

Authors:  S Nielsen; O Schmitz; N Møller; N Pørksen; I C Klausen; K G Alberti; C E Mogensen
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

5.  Protective effects of antioxidant-fortified diet on renal function and metabolic profile in obese Zucker rat.

Authors:  Yuriy Slyvka; Sharon R Inman; Ramiro Malgor; Edwin J Jackson; Jennifer Yee; Olusayo Oshogwemoh; John Adame; Felicia V Nowak
Journal:  Endocrine       Date:  2008-12-03       Impact factor: 3.633

6.  Prevalence and risk factors of microalbuminuria in Thai nondiabetic hypertensive patients.

Authors:  Pongsathorn Gojaseni; Angkana Phaopha; Worawon Chailimpamontree; Thaweepong Pajareya; Anutra Chittinandana
Journal:  Vasc Health Risk Manag       Date:  2010-03-24

7.  Leptin receptor interacts with rat chromosome 1 to regulate renal disease traits.

Authors:  Craig H Warden; Rodrigo Gularte-Mérida; Janis S Fisler; Susan Hansen; Noreene Shibata; Anh Le; Juan F Medrano; Judith S Stern
Journal:  Physiol Genomics       Date:  2012-09-11       Impact factor: 3.107

8.  Intraglomerular fibronectin accumulation and degradation in obese Zucker rats.

Authors:  L Paczek; M Teschner; R M Schaefer; A Heidland
Journal:  Diabetologia       Date:  1991-11       Impact factor: 10.122

9.  Focal sclerosing glomerulopathy. Risk factors of progression and optimal mode of treatment.

Authors:  P C Chan; K W Chan; I K Cheng; M K Chan
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

10.  Renal effects of angiotensin converting enzyme inhibitors: nondiabetic chronic renal disease.

Authors:  J A Opsahl; P A Abraham; W F Keane
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.